Cargando…

The Diagnostic and Prognostic Value of the Triglyceride-Glucose Index in Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD): A Systematic Review and Meta-Analysis

Metabolic dysfunction-associated fatty liver disease (MAFLD) has been related to a series of harmful health consequences. The triglyceride-glucose index (TyG index) appears to be associated with MAFLD. However, no consistent conclusions about the TyG index and incident MAFLD have been reached. PubMe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Jing, Yan, Shoumeng, Cui, Yani, Chen, Feinan, Piao, Meihua, Cui, Weiwei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Systematic Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9741077/ https://www.ncbi.nlm.nih.gov/pubmed/36500999 http://dx.doi.org/10.3390/nu14234969

Ejemplares similares

Association between triglyceride glucose index and risk of cerebrovascular disease: systematic review and meta-analysis
por: Yan, Feifei, et al.
Publicado: (2022)

Association between triglyceride glucose index and risk of cancer: A meta-analysis
por: Wang, Huan, et al.
Publicado: (2023)

Potential screening indicators for early diagnosis of NAFLD/MAFLD and liver fibrosis: Triglyceride glucose index–related parameters
por: Xue, Yan, et al.
Publicado: (2022)

Influence of Altered Thyroid Hormone Mechanisms in the Progression of Metabolic Dysfunction Associated with Fatty Liver Disease (MAFLD): A Systematic Review
por: Marschner, Rafael Aguiar, et al.
Publicado: (2022)

Impaired Glucagon-Mediated Suppression of VLDL-Triglyceride Secretion in Individuals With Metabolic Dysfunction–Associated Fatty Liver Disease (MAFLD)
por: Heebøll, Sara, et al.
Publicado: (2022)

Application value of triglyceride-glucose index and triglyceride-glucose body mass index in evaluating the degree of hepatic steatosis in non-alcoholic fatty liver disease
por: Wang, Mengyuan, et al.
Publicado: (2023)

Effects of Dietary Nutrients on Fatty Liver Disease Associated With Metabolic Dysfunction (MAFLD): Based on the Intestinal-Hepatic Axis
por: Yao, Nan, et al.
Publicado: (2022)

Prognostic value of triglyceride glucose index in population at high cardiovascular disease risk
por: Cai, Xiao-ling, et al.
Publicado: (2023)

Association Between Triglyceride-Glucose Index and Risk of Metabolic Dysfunction-Associated Fatty Liver Disease: A Cohort Study
por: Zhang, Ru, et al.
Publicado: (2022)

Metabolic Dysfunction-associated Fatty Liver Disease (MAFLD) and Viral Hepatitis
por: Wang, Xiaolin, et al.
Publicado: (2022)

Fibrogenic Pathways in Metabolic Dysfunction Associated Fatty Liver Disease (MAFLD)
por: Subramanian, Pallavi, et al.
Publicado: (2022)

Prognostic value of triglyceride glucose (TyG) index in patients with acute decompensated heart failure
por: Huang, Rong, et al.
Publicado: (2022)

Vitamin D and Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD): An Update
por: Barchetta, Ilaria, et al.
Publicado: (2020)

Prognostic Value of Triglyceride and Glucose Index for Incident Type 2 Diabetes beyond Metabolic Health and Obesity
por: Kim, Hwi Seung, et al.
Publicado: (2021)

Prognostic value of triglyceride-glucose index in patients with chronic coronary syndrome undergoing percutaneous coronary intervention
por: Tao, Shiyi, et al.
Publicado: (2023)

Pharmacological Therapeutics: Current Trends for Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)
por: Prasoppokakorn, Thaninee, et al.
Publicado: (2021)

A high triglyceride-glucose index is associated with left ventricular dysfunction and atherosclerosis
por: Chiu, Tai-Hua, et al.
Publicado: (2021)

Value of the triglyceride glucose index combined with body mass index in identifying non-alcoholic fatty liver disease in patients with type 2 diabetes
por: Li, Nong, et al.
Publicado: (2022)

Uncovering Actions of Type 3 Deiodinase in the Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)
por: Marschner, Rafael Aguiar, et al.
Publicado: (2023)

Metabolic dysfunction–associated fatty liver disease (MAFLD): an update of the recent advances in pharmacological treatment
por: Sangro, Paloma, et al.
Publicado: (2023)

Comparison of the diagnostic value between triglyceride-glucose index and triglyceride to high-density lipoprotein cholesterol ratio in metabolic-associated fatty liver disease patients: a retrospective cross-sectional study
por: Liu, Zhi, et al.
Publicado: (2022)

Validation of nonalcoholic fatty liver disease (NAFLD) related steatosis indices in metabolic associated fatty liver disease (MAFLD) and comparison of the diagnostic accuracy between NAFLD and MAFLD
por: Chen, Jie, et al.
Publicado: (2023)

Incremental prognostic value of triglyceride glucose index additional to coronary artery calcium score in asymptomatic low-risk population
por: Song, Shinjeong, et al.
Publicado: (2022)

Diagnostic value of triglyceride–glucose index and related parameters in metabolism-associated fatty liver disease in a Chinese population: a cross-sectional study
por: Yu, Rong, et al.
Publicado: (2023)

Cumulative triglyceride-glucose index is a risk for CVD: a prospective cohort study
por: Cui, Haozhe, et al.
Publicado: (2022)

Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)—A Condition Associated with Heightened Sympathetic Activation
por: Carnagarin, Revathy, et al.
Publicado: (2021)

Associations between red blood cell count and metabolic dysfunction-associated fatty liver disease(MAFLD)
por: Dai, Xinyi, et al.
Publicado: (2022)

A43 SEX DIFFERENCES IN THE ASSOCIATION OF HIV WITH METABOLIC DYSFUNCTION-ASSOCIATED FATTY LIVER DISEASE (MAFLD)
por: Kablawi, D, et al.
Publicado: (2023)

The Cut-off Values of Triglycerides and Glucose Index for Metabolic Syndrome in American and Korean Adolescents
por: Moon, Shinje, et al.
Publicado: (2017)

The triglyceride and glucose index (TyG) is an effective biomarker to identify nonalcoholic fatty liver disease
por: Zhang, Shujun, et al.
Publicado: (2017)

A longitudinal epidemiological study on the triglyceride and glucose index and the incident nonalcoholic fatty liver disease
por: Zheng, Rongjiong, et al.
Publicado: (2018)

The Triglyceride-Glucose Index is Associated with Vitamin D Status in Metabolic-Associated Fatty Liver Disease
por: Liu, Zhiping, et al.
Publicado: (2023)

Triglyceride-Glucose Index is Significantly Associated with the Risk of Hyperuricemia in Patients with Nonalcoholic Fatty Liver Disease
por: Qi, Jiaxin, et al.
Publicado: (2023)

MAFLD Criteria Guide the Subtyping of Patients with Fatty Liver Disease
por: Huang, Jiaofeng, et al.
Publicado: (2021)

Triglyceride-glucose index is significantly associated with the risk of hyperuricemia in patients with diabetic kidney disease
por: Li, Qiuhong, et al.
Publicado: (2022)

Triglyceride–glucose index and the incidence of atherosclerotic cardiovascular diseases: a meta-analysis of cohort studies
por: Ding, Xiaobo, et al.
Publicado: (2021)

Triglyceride-glucose index in the prediction of adverse cardiovascular events in patients with premature coronary artery disease: a retrospective cohort study
por: Wu, Zhenguo, et al.
Publicado: (2022)

The predictive value of the triglyceride—glucose index for cardiovascular events in patients with coronary chronic total occlusion
por: Li, Yingkai, et al.
Publicado: (2022)

Adipose tissue dysfunction and MAFLD in obesity on the scene of COVID-19
por: Cordeiro, Adryana, et al.
Publicado: (2022)

Triglyceride glucose-body mass index is effective in identifying nonalcoholic fatty liver disease in nonobese subjects
por: Zhang, Shujun, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_98dd66tmc74qi0t860nl49irun